| 502 | Confirmed chronic Hepatitis B infection in persons with
- HBV DNA greater than or equal to 1000 IU/mL
AND
- ALT levels greater than ULN
OR
- Evidence of fibrosis
or
- Documented evidence of cirrhosis |
| | LU Authorization Period: 1 year |
| 503 | Patients with chronic Hepatitis B infection currently receiving treatment with lamivudine and requires treatment continuation. |
| | LU Authorization Period: 1 year |
| 504 | Patients with chronic Hepatitis B infection who are scheduled to undergo chemotherapy or significant immunosuppressive treatment. |
| | LU Authorization Period: 1 year |
